Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers

International Journal of Neuropsychopharmacology

Volumn 13, Issue 6, 2010, Pages 693-702

  Perova, Tatiana ^a,b   Kwan, Melodie ^a,b   Li, Peter P ^a,b   Warsh, Jerry J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

B lymphoblasts; bipolar disorder; intracellular calcium dynamics; lamotrigine; lithium; valproate

Indexed keywords

CALCIUM; LAMOTRIGINE; LITHIUM; LYSOPHOSPHATIDIC ACID; THAPSIGARGIN; VALPROIC ACID; ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; LITHIUM CHLORIDE; TRANQUILIZER;

ADULT; ARTICLE; B LYMPHOBLAST; BIPOLAR I DISORDER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; EX VIVO STUDY; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; TREATMENT DURATION; B LYMPHOCYTE; BIPOLAR DISORDER; DRUG EFFECTS; DRUG INTERACTION; INTRACELLULAR FLUID; METABOLISM; MIDDLE AGED; PATHOLOGY; TRANSFORMED CELL LINE;

ADULT; ANTIMANIC AGENTS; B-LYMPHOCYTES; BIPOLAR DISORDER; CALCIUM; CELL LINE, TRANSFORMED; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HUMANS; INTRACELLULAR FLUID; LIPOPOLYSACCHARIDES; LITHIUM CHLORIDE; MALE; MIDDLE AGED; THAPSIGARGIN; VALPROIC ACID;

EID: 77957105188     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709000261     Document Type: Article

References (49)

1. Akimoto T, Kusumi I, Suzuki K, Masui T, et al. (2007). Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets. Journal of Psychiatry & Neuroscience 32, 17-22.
2. Andreopoulos S, Wasserman M, Woo K, Li P, et al. (2004). Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levels. Pharmacogenomics Journal 4, 365-373.
3. Bachmann RF, Schloesser RJ, Gould TD, Manji HK (2005). Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Molecular Neurobiology 32, 173-202.
4. Bowden C (2003). Valproate. Bipolar Disorders 5, 189-202.
5. Burt VK, Rasgon N (2004). Special considerations in treating bipolar disorder in women. Bipolar Disorders 6, 2-13.
6. Di Daniel E, Mudge AW, Maycox PR (2005). Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disorders 7, 33-41.
7. Du J, Suzuki K, Wei Y, Wang Y, et al. (2007). The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32, 793-802.
8. Emamghoreishi M, Schlichter L, Li P, Parikh S, et al. (1997). High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. American Journal of Psychiatry 154, 976-982.
9. First M, Spitzer R, Gibbon M, Willians JBW (1995a). Structured Clinical Interview for DSM-IV Axis I Disorders - Nonpatient Edition (SCID-I/NP, Version 2.0). New York, NY: Biometrics Research Department, New York Psychiatric Institute.
10. First M, Spitzer RL, Robert L, Gibbon M, et al. (1995b). Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). New York, NY: New York State Psychiatric Institute, Biometrics Research.
11. Fukushima N, Ye X, Chun J (2002). Neurobiology of lysophosphatidic acid signaling. The Neuroscientist 8, 540-550.
12. Gardner R (2001). Psychological Statistics using SPSS for Windows. New Jersey: Prentice-Hall Inc.
13. Goldsmith D, Wagstaff A, Ibbotson T, Perry C (2003). Lamotrigine: a review of its use in bipolar disorder. Drugs 63, 2029-2050. (Pubitemid 37229087)
14. Hahn C, Gyulai L, Baldassano C, Lenox R (2004). The current understanding of lamotrigine as mood stabilizer. Journal of Clinical Psychiatry 65, 791-804.
15. Kao JP (1994). Practical aspects of measuring [Ca2+] with fluorescent indicators. Methods in Cell Biology 40, 155-181.
16. Kato T (2008). Molecular neurobiology of bipolar disorder: a disease of mood-stabilizing neurons? Trends in Neurosciences 31, 495-503.
17. Ketter T, Calabrese J (2002). Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. Journal of Clinical Psychiatry 63, 146-151.
18. Lennkh C, Simhandl C (2000). Current aspects of valproate in bipolar disorder. International Clinical Psychopharmacology 15, 1-11.
19. Li P, Andreopoulos S, Warsh J (2000). Signal transduction abnormalities in bipolar affective disorder. In: Reith M (Ed.), Cerebral Signal Transduction: From First to Fourth Messengers (pp. 283-309). New Jersey: Humana Press Inc.
20. Li X, Bijur GN, Jope RS (2002). Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disorders 4, 137-144.
21. Manji HK, Lenox RH (1999). Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biological Psychiatry 46, 1328-1351.
22. Manji HK, Quiroz JA, Payne JL, Singh J, et al. (2003). The underlying neurobiology of bipolar disorder. World Psychiatry 2, 136-146.
23. Mattson MP, LaFerla FM, Chan SL, Leissring MA, et al. (2000). Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences 23, 222-229.
24. Muzina D, Elhaj O, Gajwani P, Gao K, et al. (2005). Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatrica Scandinavica 111, 21-28.
25. Nilsson M, Hansson E, Ronnback L (1992). Agonist-evoked Ca2+ transients in primary astroglial cultures-modulatory effects of valproic acid. Glia 5, 201-209.
26. Obrocea GV, Dunn RM, Frye MA, Ketter TA, et al. (2002). Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biological Psychiatry 51, 253-260.
27. Passmore MJ, Garnham J, Duffy A, MacDougall M, et al. (2003). Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disorders 5, 110-114.
28. Peinelt C, Vig M, Koomoa DL, Beck A, et al. (2006). Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nature Cell Biology 8, 771-773.
29. Perova T, Wasserman MJ, Li PP, Warsh JJ (2008). Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder. International Journal of Neuropsychopharmacology 11, 185-196.
30. Pinton P, Brini M, Bastianutto C, Tuft RA, et al. (1998). New light on mitochondrial calcium. Biofactors 8, 243-253.
31. Putney Jr. JW, Broad LM, Braun FJ, Lievremont JP, et al. (2001). Mechanisms of capacitative calcium entry. Journal of Cell Science 114, 2223-2229.
32. Putney Jr. JW, Ribeiro CM (2000). Signaling pathways between the plasma membrane and endoplasmic reticulum calcium stores. Cellular and Molecular Life Sciences 57, 1272-1286.
33. Quiroz JA, Gray NA, Kato T, Manji HK (2008). Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 2551-2565.
34. Roedding AS, Li PP, Warsh JJ (2006). Characterization of the transient receptor potential channels mediating lysophosphatidic acid-stimulated calcium mobilization in B lymphoblasts. Life Sciences 80, 89-97.
35. Rosskopf D, Daelman W, Busch S, Schürks M, et al. (1998). Growth factor-like action of lysophosphatidic acid in human B lymphoblasts. The American Journal of Physiology 274, C1573-C1582.
36. So J, Warsh JJ, Li PP (2007). Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biological Psychiatry 62, 141-147.
37. Soboloff J, Spassova MA, Tang XD, Hewavitharana T, et al. (2006). Orai1 and STIM reconstitute store-operated calcium channel function. Journal of Biological Chemistry 281, 20661-20665.
38. Suzuki K, Kusumi I, Akimoto T, Sasaki Y, et al. (2004). Effects of lithium and valproate on agonist-induced platelet intracellular calcium mobilization: relevance to myosin light chain kinase. Progress in Neuropsychopharmacology & Biological Psychiatry 28, 67-72.
39. Treiman M, Caspersen C, Christensen SB (1998). A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases. Trends in Pharmacological Sciences 19, 131-135.
40. Viguera A, Baldessarini R, Tondo L (2001). Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. Bipolar Disorders 3, 245-252. (Pubitemid 32982802)
41. Viguera AC, Tondo L, Baldessarini RJ (2000). Sex differences in response to lithium treatment. American Journal of Psychiatry 157, 1509-1511.
42. Warsh J, Andreopoulos S, Li P (2004). Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status. Clinical Neuroscience Research 4, 201-213.
43. Wasserman M, Corson T, Sibony D, Cooke R, et al. (2004). Chronic lithium treatment attenuates intracellular calcium mobilization. Neuropsychopharmacology 29, 759-769.
44. Xie X, Hagan RM (1998). Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38, 119-130.
45. Yamaji T, Kagaya A, Uchitomi Y, Yokata N, et al. (1996). Effects of carbamazepine and sodium valproate on 5-HT-induced calcium increase in individual C6 rat glioma cells. Neuropsychobiology 34, 22-25. (Pubitemid 26300837)
46. Yoon IS, Li PP, Siu KP, Kennedy JL, et al. (2001a). Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Molecular Psychiatry 6, 678-683.
47. Yoon I, Li P, Siu K, Kennedy J, et al. (2001b). Altered TRPC7 gene expression in bipolar-I disorder. Biological Psychiatry 50, 620-626.
48. Yuan PX, Huang LD, Jiang YM, Gutkind JS, et al. (2001). The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry 276, 31674-31683.
49. Zarate Jr. CA, Singh J, Manji HK (2006). Cellular plasticity cascades: Targets for the development of novel therapeutics for bipolar disorder. Biological Psychiatry 59, 1006-1020.